This week is National Veterinary Technician Week, and VetStem is proud to recognize the dedicated, compassionate, and skilled veterinary technicians who play a vital role in patient care. Vet techs provide hands-on care, support diagnostics and treatments, and ensure every patient receives the best possible experience. Their expertise and empathy extend beyond the exam room, touching the lives of both animals and their owners every single day.

At VetStem, we have the privilege of working closely with veterinary technicians across the country who help make regenerative medicine possible. From assisting with stem cell procedures to processing paperwork and scheduling stem cell treatments, vet techs are instrumental in every step of the process. Their attention to detail and commitment to excellence help ensure the success of VetStem Cell Therapy treatments.

Many members of our own VetStem team are former veterinary technicians, bringing their clinical experience and knowledge of animal care to every aspect of what we do. From laboratory processing to customer support and education, the VetStem team leverages this expertise to ensure the highest quality care for every patient and provide veterinarians with the guidance and support they need for successful stem cell treatments

This week, and every week, we want to express our heartfelt gratitude to veterinary technicians everywhere. Your passion, skill, and dedication make an incredible difference in the lives of animals and the people who love them. Thank you for the compassion you bring to your work and for being an essential part of the VetStem family. Happy National Veterinary Technician Week!

Last week, the VetStem team had the opportunity to sponsor and exhibit at the annual Fetch DVM360 conference in Kansas City. This event brings together veterinary professionals from across the country to learn, collaborate, and explore the latest advancements in veterinary medicine. We were proud to not only exhibit but also to sponsor two educational sessions presented by leaders in the field.

Our founder and CEO, Dr. Bob Harman, presented his session, Cell Shift: Transforming Vet Medicine with Regenerative Therapy. His talk explored the powerful potential of regenerative medicine in small animal practice, with a focus on the use of mesenchymal stem cells. Attendees gained a solid foundation in stem cell biology while also learning about evidence-based clinical applications for immune-mediated conditions, chronic kidney disease, and orthopedic disorders.

We also sponsored a session by Dr. Juli Goldstein, small animal technical services veterinarian for PetVivo Animal Health. Her lecture, Advancing Care for Osteoarthritis in Small Animal Practice, addressed osteoarthritis as a debilitating condition that can significantly impact quality of life. She reviewed the latest research on the degenerative process leading to OA and highlighted new treatment options, including joint injections such as PrecisePRP™, as part of a multimodal approach to OA management.

In addition to these educational sessions, our team enjoyed connecting with veterinarians and technicians in the exhibit hall. These conversations provided an excellent opportunity to discuss the benefits of VetStem Cell Therapy and how regenerative medicine can be integrated into clinical practice to improve outcomes for patients.

We’d like to thank Fetch DVM360 for hosting another successful conference and all of the veterinary professionals who stopped by our booth to learn more about stem cell therapy. We look forward to continuing the conversation and advancing the role of regenerative medicine in veterinary care.

VetStem CEO, Dr. Bob Harman, with PetVivo technical services vet, Dr. Juli Goldstein

Dr. Harman’s lecture “Cell Shift: Transforming Vet Medicine with Regenerative Therapy”

Dr. Goldstein’s lecture “Advancing Care for Osteoarthritis in Small Animal Practice”

Every year, National Take Your Cat to the Vet Day serves as an important reminder of how vital regular veterinary care is for our feline companions. Despite this, statistics show that cats are brought in for routine check-ups far less frequently than dogs. One major reason? Cats are experts at hiding pain and illness, often showing no outward signs until a condition has significantly progressed.

That’s why routine veterinary visits are so crucial. They give your vet the opportunity to detect early warning signs of disease and recommend proactive treatments that can improve your cat’s comfort and quality of life. One such innovative treatment option is VetStem Cell Therapy, which uses your cat’s own stem cells to promote healing and reduce inflammation. At VetStem, we’ve seen great results helping cats with osteoarthritis regain mobility and reduce pain.

Beyond arthritis, stem cells have shown promise in treating chronic kidney disease, gingivostomatitis (a painful oral disease), and inflammatory bowel disease. Check out our recent blog for more information about VetStem Cell Therapy for these hard-to-treat conditions in cats.

If you’re considering VetStem Cell Therapy for your cat, we’re here to help you every step of the way. Here’s a quick overview of how the process works:

1. Collection: Your veterinarian collects a sample of fat tissue from your cat during a minor procedure performed under anesthesia.
2. Processing: The sample is sent overnight in a temperature-controlled container to our VetStem lab, where technicians isolate and concentrate your cat’s stem cells.
3. Treatment: Stem cell doses are then shipped back to your veterinarian for immediate injection. Any remaining cells will be cryopreserved for potential future use.

The entire procedure is designed to be minimally invasive and focused on your cat’s comfort and safety.

Our cats may not always tell us when something is wrong, but regular veterinary care, and staying informed about treatment options like VetStem Cell Therapy, can make a world of difference in their well-being. This National Take Your Cat to the Vet Day, consider scheduling your cat for a check-up and ask your vet if stem cell therapy could be right for your feline friend.

Need a list of VetStem providers near you? Contact us today!

VetStem had the privilege of exhibiting at the 2025 Western Veterinary Conference (WVC) this week, one of the largest and most anticipated events in veterinary medicine. As leaders in regenerative medicine, VetStem showcased its innovative stem cell therapy and off-the-shelf PRP products, which are revolutionizing how veterinarians treat a number of diseases and injuries.

This year, we were excited to announce the news that we entered into an Exclusive License and Supply Agreement with Petvivo Animal Health, Inc. to commercialize our innovative allogeneic orthobiologic products, PrecisePRP™ Canine and PrecisePRP™ Equine. PrecisePRP™ is a groundbreaking, off-the-shelf platelet-rich plasma (PRP) product designed for ease of use by veterinarians. Unlike traditional PRP mechanical kits that require a blood draw and centrifugation, PrecisePRP™ is ready-to-use, offering veterinarians a truly off-the-shelf product that is easy and convenient. More importantly, PrecisePRP™ ensures uniformity and consistency with its unique patent-pending manufacturing process and quality testing.

Additionally, attendees had the opportunity to learn about VetStem’s groundbreaking advancements in stem cell technology, which are helping thousands of pets recover from injuries, arthritis, and other challenging conditions like renal disease, inflammatory bowel disease, gingivostomatitis, back pain/IVDD, and dry eye.

We were thrilled to connect with veterinarians and industry professionals at the event. It was a great opportunity to share how VetStem’s regenerative solutions are improving the health and quality of life for animals everywhere. Thank you to everyone who stopped by and made our time at WVC 2025 such a success. We look forward to continuing to drive advancements in veterinary care and supporting the veterinary community in the years to come!

As we celebrate Veterinary Assistant Appreciation Week, it’s important to reflect on the critical role veterinary assistants play in the care and well-being of our beloved pets. These dedicated professionals provide invaluable support to veterinarians and veterinary teams by assisting with patient care, managing medical records, and ensuring that the practice runs smoothly. Their passion for animals and commitment to their work make a lasting impact on the veterinary field, and at VetStem, we are proud to honor their hard work and dedication.

Many of our team members at VetStem know firsthand the demands and rewards of being a veterinary assistant. In fact, several of our employees started their careers in veterinary medicine as assistants before transitioning into their current roles. These individuals bring a unique perspective and wealth of hands-on experience to their work, allowing them to better serve our veterinary clients. Their backgrounds as veterinary assistants have shaped the compassionate and patient-focused approach that defines the culture at VetStem.

We are grateful to the veterinary assistants who continue to inspire and contribute to the success of our industry. Their skills, empathy, and unwavering commitment to animals are essential to every veterinary practice, and we are proud to have many of these exceptional individuals as part of the VetStem family. This week, we take a moment to express our heartfelt appreciation for all that veterinary assistants do to support veterinary teams and improve the lives of animals everywhere.

We’re just about to the end of 2024, and it’s been an exciting year at VetStem. This year we were pleased to announce the commercial launch of our FDA-reviewed off-the-shelf PRP product, PrecisePRP. As we do every year, we’re wrapping up the VetStem blog with some highlights from the last 12 months. So, without further ado, here is VetStem’s 2024 year in review!

• In early 2024, we announced that VetStem reached a significant industry leading milestone. As of February, we had processed over 16,000 patient samples resulting in over 38,000 stem cell treatments.
• At the same time, two of our most prolific small animal users reached a milestone in stem cell cases. Drs. Jeff Christiansen and Kim Carlson both surpassed 300 cases. To date, Dr. Christiansen has performed 342 stem cell collections and Dr. Carlson has performed 326 – wow!
• In mid April, VetStem sponsored a lab at the annual IVAPM Pain Management Forum for the third year in a row. Veterinarians at this forum have a particular interest in multi-modal pain management and were excited to learn about PrecisePRP.
• Later in April, we were thrilled to announce that our latest platelet-rich plasma product, PrecisePRP Canine, had completed FDA review and officially became the first FDA-reviewed allogeneic off-the-shelf cell medicine product in the U.S.
• Shortly afterward, we announced the launch of PrecisePRP Equine, the second allogeneic cell medicine product to complete FDA-review.
• In May, the VetStem Sales and Marketing team was in Nashville where we sponsored and exhibited at the Fetch DVM360 Nashville veterinary conference. VetStem proponent and pain specialist Dr. Jamie Gaynor delivered two lectures about stem cell therapy and platelet-rich plasma.
• In July, we shared a fun update about a Sichuan Takin that received VetStem Cell Therapy for arthritis.
• August saw the VetStem Sales and Marketing team in Kansas City, MO for the annual Fetch DVM360 conference. We sponsored and exhibited at this show where our CEO, Dr. Bob  Harman, delivered two lectures about regenerative medicine.
• In October, we released updated efficacy data for PrecisePRP Canine. Out of 59 dogs who received PrecisePRP for orthopedic conditions, 47 of them showed significant improvement!
• Also in October, the Sales and Marketing team was back on the road at the Fetch Coastal veterinary conference in Atlantic City, NJ. VetStem proponent Dr. Alistair Chapnick delivered two lectures on stem cell therapy and PRP.
• In early December, the Sales and Marketing team wrapped up a busy year of conferences at the final Fetch DVM360 conference in Long Beach, CA. At this show, Drs. Bob Harman and Jamie Gaynor teamed up to deliver two lectures about comprehensive management of osteoarthritis and regenerative medicine.

So, there you have it. Another year in the books. It was an exciting year for us and, as always, we couldn’t do what we do without the support of our veterinary and pet owner clients. We hope that you and your loved ones have a wonderful holiday season, and we look forward to seeing what 2024 has in store for VetStem!

Last weekend, the VetStem Sales and Marketing team had the privilege of sponsoring, speaking, and exhibiting at the DVM360 Fetch Veterinary Conference in Long Beach, CA. Attending these veterinary conferences is always a fantastic opportunity for us to connect with both current and potential clients in person. At nearly every conference, we run into someone who has had their own pet treated with VetStem Cell Therapy. It’s always inspiring to hear their success stories firsthand!

At this year’s Fetch Long Beach event, our CEO, Dr. Bob Harman, co-presented with pain specialist and VetStem enthusiast, Dr. Jamie Gaynor. Their first lecture focused on a comprehensive approach to managing osteoarthritis. While stem cell therapy is a valuable option for pets with arthritis, many animals benefit from a multimodal treatment plan. The session explored the combination of traditional treatments like NSAIDs and physical rehabilitation with cutting-edge therapies, including CBD and regenerative medicine techniques like stem cell therapy and platelet-rich plasma (PRP). A holistic approach to canine osteoarthritis could lead to more effective outcomes.

In their second lecture, Drs. Harman and Gaynor discussed the broad range of conditions for which pets have received both VetStem Cell Therapy and PRP. While orthopedic conditions such as osteoarthritis and soft tissue injuries continue to be the primary use for stem cells, many pets have also received stem cell therapy for internal medicine conditions such as kidney disease, inflammatory bowel disease, and more! Likewise, PRP has been used for a number of years to manage conditions such as wound healing and corneal ulcers.

As we conclude the 2024 conference season, we want to express our gratitude to everyone who visited our booth and attended our presentations. We are excited to collaborate with many of you in the year ahead!

One Health Day, celebrated on November 3rd each year, emphasizes the interconnectedness of human, animal, and environmental health. According to www.onehealthday.com, “One Health Day answers the urgent need for a One Health trans-disciplinary approach towards solving today’s critical global health challenges.” By fostering collaboration between veterinary and human medicine, we can develop innovative solutions that benefit all species.

Translational medicine plays a crucial role in this integration by facilitating the transfer of knowledge and research findings from animal studies to human applications. This approach has been particularly evident in the field of regenerative medicine, where advances in veterinary practices have paved the way for groundbreaking treatments in humans. VetStem has been at the forefront of stem cell therapy for veterinary patients for the last two decades. Our research and successful treatments in animals have informed human medical practices, showcasing how innovations in veterinary medicine can lead to significant breakthroughs in human health.

VetStem’s commitment to translational medicine culminated in the establishment of Personalized Stem Cells Inc., a company that focuses on developing stem cell therapies for human patients. By harnessing the advancements made in veterinary medicine, Personalized Stem Cells aims to create personalized treatment options for a variety of human ailments, including degenerative diseases and injuries, through their cell banking programs. This transition highlights the value of veterinary research as a vital resource for human healthcare advancements, underscoring the principle of One Health—where health solutions are derived from a comprehensive understanding of biological systems across species.

Earlier this week, the VetStem Sales and Marketing Team exhibited at the annual Fetch Coastal veterinary conference in Atlantic City, NJ. This marks our second time sponsoring this event. Veterinary conferences are a valuable opportunity to connect with our fellow veterinary professionals, share knowledge, and strengthen our industry relationships.

This year, one of VetStem’s experienced small animal users, Dr. Alistair Chapnick of Spot On Veterinary Hospital, delivered two talks at the conference. His first lecture explored the expanding role of stem cell therapy in veterinary medicine. While many are familiar with its use in orthopedics for conditions like osteoarthritis and tendon injuries, recent advancements have highlighted its potential in treating more complex diseases, including kidney failure, inflammatory bowel disease, and gingivostomatitis. Numerous patients have experienced significant benefits from VetStem Cell Therapy for these challenging conditions.

In his second lecture, Dr. Chapnick focused on the diverse applications of platelet-rich plasma (PRP) in veterinary medicine. As a cell-based therapy, PRP has shown remarkable success in promoting healing in areas such as orthopedics, wound care, and corneal ulcers. Dr. Chapnick reviewed current literature, presented case studies, and assessed the safety and effectiveness of PRP. He also introduced VetStem’s latest innovation, PrecisePRP™, an off-the-shelf freeze-dried PRP solution. In last week’s blog, we covered some outcome data for PrecisePRP Canine. You can check it out here.

If you missed us in Atlantic City, be sure to catch us at Fetch Long Beach in December or Western Veterinary Conference in March 2025!

This week, we are sponsoring, speaking, and exhibiting at the annual Fetch DVM360 Veterinary Conference in Kansas City, MO. This is our second time sponsoring this show in recent years. Veterinary conferences are a great way for us to get in front of our colleagues in the field to educate and further develop those relationships.

This year, Dr. Bob Harman will deliver two lectures at the conference. The first is about the many uses of platelet-rich plasma (PRP) in veterinary medicine. PRP is a cell-based therapy that has been used in veterinary medicine for healing in orthopedics, wounds, corneal ulcers, and more. Dr. Harman will examine the literature and present a few case studies to evaluate the safety and efficacy of PRP. He will also do a deep dive into our latest product, an off-the-shelf freeze-dried PRP, PrecisePRP™.

His second talk will delve into the world of stem cell therapy. Most of us know that stem cells are primarily used in orthopedics for things such as osteoarthritis and injured tendons/ligaments. But in recent years, stem cells have shown great promise in treating some complicated diseases such as kidney failure, inflammatory bowel disease, and gingivostomatitis. Numerous patients have benefited from treatment with VetStem Cell Therapy for these conditions.

If you happen to be at the show, come visit the VetStem team at booth #1200!